GALMED PHARMACEUTICALS LTD's ticker is GLMD and the CUSIP is M47238106. A total of 32 filers reported holding GALMED PHARMACEUTICALS LTD in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $254,000 | -21.6% | 72,640 | +8.4% | 0.01% | -27.3% |
Q2 2020 | $324,000 | +126.6% | 66,991 | +61.2% | 0.01% | +57.1% |
Q1 2020 | $143,000 | -33.8% | 41,548 | +9.8% | 0.01% | -12.5% |
Q4 2019 | $216,000 | -5.3% | 37,856 | -19.0% | 0.01% | 0.0% |
Q3 2019 | $228,000 | -19.1% | 46,734 | +3.3% | 0.01% | -11.1% |
Q2 2019 | $282,000 | +2.9% | 45,222 | +34.7% | 0.01% | -30.8% |
Q1 2019 | $274,000 | +15.6% | 33,573 | -3.1% | 0.01% | +18.2% |
Q4 2018 | $237,000 | -25.0% | 34,656 | +48.9% | 0.01% | -8.3% |
Q3 2018 | $316,000 | +315.8% | 23,274 | +54.5% | 0.01% | +140.0% |
Q1 2018 | $76,000 | -36.1% | 15,068 | +19.1% | 0.01% | -44.4% |
Q4 2017 | $119,000 | – | 12,655 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|